ERIN TANT: Open Payments
NPI 1285930024 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 58 payments from 18 companies in 2025. Trend: 2023 $688 · 2024 $721 · 2025 $1,016
Food & beverage: $971Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $283 |
| PFIZER INC. | 11 | $184 |
| Novo Nordisk Inc | 9 | $153 |
| Amgen Inc. | 3 | $51 |
| Abbott Laboratories | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Boston Scientific Corporation | 1 | $31 |
| ABBVIE INC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: MOUNJARO, NURTEC ODT, Wegovy, PREVNAR 20, JARDIANCE, ELIQUIS, Ozempic, Rybelsus.
Industry payments across GA — which companies pay providers there.
